Open Door Salon

Open Door Salon
  • 0.0 (0)
  • MEDICINE
  • UPDATED WEEKLY

The healthcare system is broken. Open Door Salon is a place where patients can find an easier way to navigate treatment—and where those working within the system can come together to solve the problems they hear about every day. Change starts with conversation.

Episodes

  1. 4D AGO

    "Bikini Medicine" Is Killing Us | Why Women's Health Is Still Decades Behind

    Katie Schubert is President & CEO of the Society for Women's Health Research — 35+ years advocating for sex differences research. Former Capitol Hill staffer. Her goal: make women's health so mainstream that her organization goes out of business. Joanna Stickler is VP of Health Policy & External Affairs at Roche Diagnostics. Former public health professional. Her mantra: we haven't even implemented A, B, and C before demanding X, Y, and Z. In Today's Episode: What famines teach us about transgenerational healthWhy pregnancy sets the stage — but nobody's tracking it1 in 5 women left or considered leaving their jobs due to menopause"Bikini medicine" and why women's health needs a rebrandWomen weren't included in clinical research until 1993Endometriosis, PCOS, and the diseases we're ignoringThe 9-minute primary care appointment isn't working

    59 min

  2. FEB 18

    "Cash Is Oxygen" | Frank Watanabe & Josh Fessel Get Real on Surviving Biotech's Chaos

    Frank Watanabe is the President and CEO of Arcutis Biotherapeutics, a dermatology biotechnology company based in Los Angeles. He's also the Vice Chairman of BIO. Frank spent 30 years in biopharma after a prior career in national security — he stumbled into the industry at Eli Lilly and stayed for the mission. Josh Fessel is a physician-scientist who most recently served as Chief Medical Officer and Director of the Office of Translational Medicine at NCATS (National Center for Advancing Translational Sciences) at the NIH. He left federal service approximately 7-8 months ago after the landscape shifted in ways that conflicted with his values and oaths as a physician. In Today's Episode We Discuss: Cash Is Oxygen: Advice for CEOs in a Tough Funding EnvironmentThe AI Bubble & Why It Popping Might Be Good for BiotechThe 8-10 Year Divot in Basic Research That's ComingBrain Drain: Canada, France & Australia Are Recruiting US ScientistsChina's Rise & Why the Me-Too Strategy Is DeadState-Level Innovation: "50 Kids in a Trench Coat"Coopetition as a Survival StrategyThe Hardest Decisions: Layoffs & Leaving Federal ServiceConnect with Open Door Salon:LinkedIn I YouTube⁠ I Website

    49 min

  3. FEB 11

    The $50,000 Cure Problem: Why the US Can't Do What India Already Did | Andy Holt & Phil Vanek

    Andy Holt is the Chief Commercial Officer at Viralgen Vector Core, a company specializing in the contract manufacture of AAV gene therapies. A self-described "really bad molecular biologist" who moved to the commercial side, Andy has spent 18 years in cell and gene therapy, including a stint as VP at AskBio before its acquisition by Bayer. Phil Vanek is the Chief Commercialization Officer at ISCT (International Society for Cell and Gene Therapy). Another former bench scientist who decided to "head into the business world," Phil has built his career in product development, innovation leadership, and investing on behalf of private equity. In Today's Episode We Discuss: Why Clinical Adoption Isn't Keeping Up with ApprovalsCAR-T for $50,000 in India — Why Can't the US Do This?The $4 Million Problem: Employment-Linked Healthcare Breaks EverythingFirst-in-Human Trials in Under a Year for Under $20 MillionNIH Funding Uncertainty: Spend Every Dollar Like It's Your LastWhy AI Is a "Shiny Object" Siphoning CapitalAdvice for Startups: "Hunt for Boring"Advice for Investors: "Don't Drink the Kool-Aid"(00:00) Intro & Meet the Guests (03:12) Why Clinical Adoption Isn't Keeping Up with Approvals (06:44) Manufacturing Cost Is No Longer the Biggest Problem (10:02) The Education Problem: Clinicians Are Learning Too (14:20) Payers Think Like Investors — Here's What That Means (17:46) The $4 Million Problem: Why Employment-Linked Healthcare Breaks Everything (23:26) What Challenges Are Companies Facing Right Now? (27:49) First-in-Human in Under a Year for Under $20 Million (31:24) NIH Funding Uncertainty: Spend Every Dollar Like It's Your Last (37:01) Instability Creates Opportunity — But Also Higher Risk (42:08) Advice for Startups: Hunt for Boring (44:25) Advice for Investors: Don't Drink the Kool-Aid (46:38) Why They Chose This Industry (52:37) Closing Connect with Open Door Salon:LinkedIn I YouTube

    53 min

  4. FEB 3

    "Everything Everywhere All at Once" | Colin Zick & Anne Li on Biotech's Legal and Regulatory Chaos

    Colin Zick is a Partner at Foley Hoag, where he co-chairs both the Health Care Compliance practice and the Privacy & Data Security practice. With over 30 years of experience navigating healthcare regulation and cybersecurity, Colin has seen administrations come and go—and knows that the fundamentals of compliance never change, even when everything else does. Anne Herold Li is a Shareholder at Brownstein Hyatt Farber Schreck, where she serves as Managing Partner of the New York office and co-chairs the Life Sciences practice. A former epidemiologist who was once the "Rat Queen of New York City," Anne pivoted to law after her brother suggested she might enjoy patent law—where someone pays you to learn the latest science every day. In Today's Episode We Discuss: Supreme Court Tariff Ruling & What It Means for 300,000+ CompaniesThe Biosecure Act Is Back — With Immediate ImpactAI Regulation: US "Hold My Beer" vs. EU's Tricycle ApproachWhy Companies Actually Want to Be RegulatedEffective Lobbying: Tell Your Story Like HamiltonThe Boring But Critical: Tax, Insurance & Force MajeureConnect with Open Door Salon: LinkedIn I Instagram I YouTube I Website #biotech #lifesciences #patent #biosecurity #tariffs #drugdevelopment #AI #healthcare #pharma #OpenDoorSalon #ODS

    1 hr

  5. TRAILER

    Where the Healthcare Industry & Patients Can Finally Talk

    A place where healthcare finally talks to itself. Open Door Salon brings together patients, providers, and industry leaders to tackle the broken healthcare system—one conversation at a time. Whether you're navigating treatment or working within the system, this is where change begins.

    1 min

Trailer

About

The healthcare system is broken. Open Door Salon is a place where patients can find an easier way to navigate treatment—and where those working within the system can come together to solve the problems they hear about every day. Change starts with conversation.

Information

  • Creator
    Open Door Salon
  • Years Active
    2K
  • Episodes
    5
  • Rating
    Clean
  • Copyright
    © Open Door Salon
  • Show Website
    Open Door Salon